UCSF Researchers Identify FTL1 Protein as Key Factor in Brain Aging and Potential Reversal
By
stevenjgarner
A touch underbaked. Edible, but you'll want a strong coffee alongside.
Summary
Researchers at UC San Francisco have discovered that a protein called FTL1 plays a central role in brain aging. In mice studies, older animals showed elevated FTL1 levels, which correlated with reduced brain cell connections, diminished cognitive abilities, and memory loss. When researchers artificially increased FTL1 in young mice, they developed aging-like symptoms, while blocking FTL1 in older mice restored youthful brain function and memory. The findings suggest FTL1 could be a master switch for brain aging, potentially opening pathways to reverse cognitive decline rather than just slowing it down.
Key quotes
· 4 pulledOld mice had more FTL1, as well as fewer connections between brain cells in the hippocampus and diminished cognitive abilities
When the researchers artificially increased FTL1 levels in young mice, their brains and behavior became like those of old mice
But when researchers blocked it, the animals regained youthful brain function and sharp memory
The discovery suggests that one protein could be the master switch for aging in the brain — and targeting it may one day allow us to actually reverse cognitive decline, not just slow it down
You might also wanna read
Study Examines Effects of Intermittent Hypoxia on Executive Function and Cognitive Performance
This scientific research article examines the effects of intermittent hypoxia (alternating breathing of normoxic and hypoxic gas mixtures) o
onlinelibrary.wiley.com·5mo ago
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·1h ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·2h ago
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
bbc.co.uk·5h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·6h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·7h ago